Examination of Japanese cases of gynecological cancer offers a better understanding of the profile of a rare ovarian tumor and could change treatment guidelines. Ovarian granulosa cell tumors are a rare type of ovarian cancer that affect the ovaries and fallopian tubes, and can extend further into the pelvis and...
Latest News
The University of California, San Francisco (UCSF) and the Multiple Myeloma Research Foundation (MMRF) have established the Stephen and Nancy Grand Multiple Myeloma Translational Initiative, a research collaboration dedicated to translating basic science discoveries into new candidate drugs for testing in clinical trials. The initiative, known as MMTI, was launched...
A first of its kind study by Cancer Research UK reveals premature cancer death rates in 35–69-year-olds fell by more than a third over 25 years Improvements in the UK are a result of smokefree policies, prevention measures, early detection programmes like cancer screening, and more effective treatment options...
TEL AVIV, Israel – Gaucher disease (GD), a rare autosomal recessive disorder, is characterized by the deficiency of the lysosomal enzyme β-glucocerebrosidase, leading to the accumulation of glucosylceramide in macrophages throughout the body. Accordingly, the primary disease features are hepatosplenomegaly, hypersplenism, anemia, thrombocytopenia, and bone involvement. There are three types...
Turku, Finland – Researchers at the University of Turku, have uncovered how the new bexmarilimab therapy alters the function of immune cells so that they can infiltrate the tumor in cancer patients who do not respond to any other current therapies. Cancer immunotherapy utilizes the body’s own defense machinery, the...
Düsseldorf, Germany – A recent case report from Germany highlights the potential of blinatumomab, a cancer therapy, in treating refractory generalized myasthenia gravis (gMG)— a form of the autoimmune disease that does not respond to standard treatments. Two women with severe, treatment-resistant MG experienced marked clinical improvements following treatment with...
San Antonio, Texas – A promising new cancer therapy also appears extremely potent against one of the world’s most devastating infectious diseases: tuberculosis (TB). Scientists at Texas Biomedical Research Institute (Texas Biomed) found the therapy dramatically reduces TB growth, even for bacteria that are drug-resistant. The findings, reported in the journal...
ATLANTA – Cancer Treatment Centers of America® (CTCA) Atlanta has launched its Women’s Cancer Center, led by an experienced roster of fellowship-trained, board-certified physicians and clinicians with expertise in breast and gynecologic oncology. The center offers comprehensive cancer care – from screenings, diagnostic evaluations and treatment plans to supportive care...
Kyoto, Japan — An old campaign slogan for cough syrup, “It tastes awful. And it works,” seemed to imply that any sweet content might have diminished the medicinal effect. Sweetness, in the case of cancer, appears as a chain of sugar molecules attached to proteins by beta1,4-galactosyltransferase-3, or B4GALT3 According...
Lehi, Utah — CancerVAX, Inc., developer of a breakthrough universal cancer vaccine that will use the body’s immune system to fight cancer, reported that CEO Ryan Davies discussed the future of the cancer therapeutic industry with Dr. Looper, a life-long researcher in the chemistry field. Ryan Looper, Ph.D., Colorado State...